In vitro activity of cysteamine against SARS-CoV-2 variants
Article
[키워드] acute respiratory syndrome
Alpha
antiviral activity
application
Breakthrough infection
caused
Concentration
Contagion
Continuous
coronavirus
COVID-19 pandemic
Culture
cysteamine
Cysteamine HCl
cystinosis
Disulfides
effective
FDA-approved drug
HCl
in vitro
individuals
Infection
inhibit
inhibited
less
limit
mitigate
nasal
Nasal spray
ocular
Omicron variant
ophthalmic
Orphan
Orphan Drug
Patient
populations
Prevent
QID
receive
required
SARS CoV-2
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 variant
shown
Spread
tissue
Transmission
treat
Treatment
vaccinated individual
Vaccine
variant
variants of SARS-CoV-2
Vero Cell
viral inhibition
while
wild type
[DOI] 10.1016/j.ymgme.2022.08.009 PMC 바로가기
[DOI] 10.1016/j.ymgme.2022.08.009 PMC 바로가기